BUSINESSJun 23 · 04:00 UTCFINANCIAL TIMES WORLD

Eli Lilly deploys weight-loss cash on ‘App Store’ for scientists

Eli Lilly, the maker of Mounjaro, is using funds from its weight-loss drug to develop an 'App Store' for scientists. The company is collaborating with small biotechs to leverage AI as a tool for drug discovery.

Nexus surfaces and summarizes. The full story lives at the source.

Mentioned

Eli LillyorganizationMounjarotopicsmall biotechstopicAItopicdrug discoverytopicApp Storetopic

Spot something wrong with this article?Report a problem →

Forward this

Related Signal

Adjacent reporting

BUSINESSApr 14 · 15:02 UTC
Novo Nordisk partners with OpenAI in weight loss drug race
HEALTHMay 21 · 10:45 UTC
People lost up to 85 pounds on Lilly’s experimental weight loss drug, company says
HEALTHMay 7 · 10:37 UTC
New “Trojan horse” obesity drug supercharges weight loss in early tests
HEALTHJun 22 · 01:28 UTC
The Thriving Black Market for a Powerful Weight Loss Drug
HEALTHApr 13 · 02:34 UTC
Stanford scientists discover “natural Ozempic” without side effects